新闻/Reuters/Sino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaSino Biopharmaceutical Says TQB2102 Included In Breakthrough Therapeutic Designation Process In ChinaRefinitiv阅读少于1分钟1177Sino Biopharmaceutical Ltd 1177:TQB2102 INCLUDED IN BREAKTHROUGH THERAPEUTIC DESIGNATION PROCESS IN CHINAReuters中国股票中国香港股票亚洲© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
